I-1000233

N/A

Report date: 2024/04/22 16:54:33

Base Information

Drug NameI-1000233
Drug Alias NameI-1000233
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitors
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsBrain NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIrbm SPA
China Registration ClassN/A

Develop Information

Active CompaniesIrbm SPA
Inactive CompaniesN/A
Active IndicationsBrain NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A